Testing the Addition of KRT-232 (AMG 232) to Usual Chemotherapy for Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1
Clinical Trials Related to Carfilzomib
Related studies linked through entity extraction aliases.
Carfilzomib in Combination With Dexamethasone (Kd) in Chinese Patients With Relapsed & Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE3
2015-12: A Study Exploring the Use of Early and Late Consolidation/Maintenance Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Non-interventional Study of Kyprolis® in Combination With Revlimid® and Dexamethasone or Dexamethasone Alone or in Combination With Darzalex® and Dexamethasone in Multiple Myeloma Patients
- Status
- COMPLETED
- Phase
- N/A
Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
High Dose Carfilzomib for Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Venetoclax in Combination With Carfilzomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma (MM)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy
- Status
- COMPLETED
- Phase
- PHASE2
Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Induction Therapy for Multiple Myeloma With Carfilzomib, Lenalidomide,Dexamethasone,Panobinostat
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Other Treatments in Subjects With Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Trial of Carfilzomib, Lenalidomide, Dexamethasone Versus Lenalidomide Alone After Stem-cell Transplant for Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Selinexor, Carfilzomib, and Dexamethasone Versus Placebo, Carfilzomib, and Dexamethasone in Multiple Myeloma
- Status
- WITHDRAWN
- Phase
- PHASE2
High-Dose Weekly Carfilzomib Plus Cyclophosphamide and Dexamethasone in the Treatment of Relapsed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Dose Escalation Study of Carfilzomib Taken With Thalidomide and Dexamethasone in Relapsed AL Amyloidosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children
- Status
- COMPLETED
- Phase
- PHASE1
Carfilzomib in Treating Patients With Chronic Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE2
Combination Therapy With Carfilzomib for the Antibody-Mediated Rejection Diagnosis in Lung Transplantation
- Status
- COMPLETED
- Phase
- PHASE2
B-Cell Targeted Carfilzomib Desensitization
- Status
- UNKNOWN
- Phase
- PHASE1
Carfilzomib in Treatment Patients Under 65 Years With High Risk Smoldering Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2